Clinical trials: HTLV-1
Human T-Lymphotrophic Virus Type I and/or Type II
Evaluation of InnoLIA HTLV I/II Score
The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples.
- Trial name
- NCT01149837
- Testing
- InnoLIA HTLV I/II Score line immunoassay
- Where
- United States
- Volunteers
- 3,305 people, healthy volunteers welcome
- Sponsor
- Creative Testing Solutions
Tropical Spastic Paraparesis
MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
This study will use three different magnetic resonance imaging (MRI) techniques to study HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/STP)-a disease of slowly progressive weakness in the legs.
- Trial name
- NCT00034723
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
HTLV-I Infection, Tropical Spastic Paraparesis
Evaluation of Patients With HAM/TSP
Objective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less than 5% of patients infected with the HTLV-I virus.
- Trial name
- NCT00001778
- Where
- United States
- Volunteers
- 750 people, healthy volunteers welcome
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
HTLV-I Infections
Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
Only 5 to 10% of patients infected with HTLV-1 develop a disease related to infection. The two most serious diseases are adult T-cell leukemia (ATL) and Tropical spastic paraparesis /HTLV-I-associated myelopathy (TSP / HAM).
- Trial name
- HAMIL28B (NCT01754311)
- Where
- 2 sites in Martinique
- Volunteers
- 155 people, healthy volunteers welcome
- Sponsor
- University Hospital Center of Martinique
HIV, HTLV-1
Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa
Kinshasa, Democratic Republic of Congo (DRC), is where human immunodeficiency virus type 1 (HIV-1) appears to have most diversified.
- Conditions
- HIV, HTLV-1, Hepatitis C, Chronic
- Trial name
- NCT02439918
- Volunteers
- 839 people, healthy volunteers welcome
- Sponsor
- Université de Sherbrooke
HTLV-1
Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus
Testing the effectiveness of an exercise protocol engines sensory performed through a virtual reality platform in individuals infected with HTLV-1
- Trial name
- NCT02877030
- Testing
- Video game
- Where
- Brazil
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Pedreira, Érika, M.D.